In Reply We thank Shah et al, Bentzen et al, and Fastner et al for their comments on our randomized clinical trial of delayed second-procedure targeted intraoperative radiotherapy (TARGIT-IORT).1 We address their points here.
No takes yet. Share an insight, caveat, or question.
Vaidya et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: